Compare Cigna Corp (CI) vs Jumia Technologies AG - ADR (JMIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Jumia Technologies AG - ADR — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Jumia Technologies AG - ADR trades at $5.96 (market cap $743.12M). The key difference: Cigna Corp is far larger — about 99× Jumia Technologies AG - ADR's market cap, and Cigna Corp pays a 2.24% dividend while Jumia Technologies AG - ADR pays none. Which is the better fit depends on your goals.
| CI | JMIA | |
|---|---|---|
Market Cap | $73.56B | $743.12M |
Sector | Health | Consumer Cyclical |
52-Week High | $311.00 | $14.60 |
52-Week Low | $244.41 | $5.69 |
Enterprise Value | $98.27B | $690.21M |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
JMIA trades at $6.19, up 8.79% today, but remains in a bearish technical trend with mixed signals from moving averages and oscillators. Fundamentally, the company shows improving revenue trends ($189M in 2025) and narrowing losses, though it continues to post negative net income margins (-30.79%). Recent news highlights management's focus on achieving profitability by 2027 through strategic partnerships and expansion initiatives.
While analyst consensus remains strongly bullish (71% buy ratings), JMIA faces significant execution risks in its path to profitability. The stock presents speculative upside potential if the company can deliver on its 2027 profitability targets, but investors should weigh the substantial losses against the promising revenue growth trajectory in African e-commerce markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Jumia Technologies AG - ADR
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →
